Point72 Hong Kong LTD Apellis Pharmaceuticals, Inc. Transaction History

Point72 Hong Kong LTD

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$44.76 - $69.66 $42,522 - $66,177	950 New	950 $65,000
Q2 2022 Aug 15, 2022	SELL	$35.07 - $59.21 $146,627 - $247,557	-4,181 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$35.46 - $54.12 $121,273 - $185,090	3,420 Added 449.41%	4,181 $212,000
Q4 2021 Feb 14, 2022	SELL	$30.74 - $49.16 $252,621 - $403,996	-8,218 Reduced 91.52%	761 $36,000
Q3 2021 Nov 15, 2021	BUY	$31.4 - $69.84 $91,750 - $204,072	2,922 Added 48.24%	8,979 $296,000
Q2 2021 Aug 16, 2021	BUY	$40.9 - $64.9 $247,731 - $393,099	6,057 New	6,057 $383,000
Q4 2020 Feb 16, 2021	SELL	$30.79 - $57.2 $13,424 - $24,939	-436 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$25.89 - $33.65 $23,145 - $30,083	-894 Reduced 67.22%	436 $13,000
Q2 2020 Aug 14, 2020	BUY	$24.8 - $38.49 $5,307 - $8,236	214 Added 19.18%	1,330 $43,000
Q1 2020 May 15, 2020	BUY	$17.91 - $44.33 $19,987 - $49,472	1,116 New	1,116 $30,000
Q4 2019 Feb 14, 2020	SELL	$22.1 - $30.8 $884 - $1,232	-40 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$24.09 - $32.18 $963 - $1,287	40 New	40 $1,000
Q2 2019 Aug 14, 2019	SELL	$18.0 - $25.34 $2,466 - $3,471	-137 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$12.81 - $19.82 $1,268 - $1,962	-99 Reduced 41.95%	137 $3,000
Q4 2018 Feb 14, 2019	BUY	$11.47 - $18.71 $2,706 - $4,415	236 New	236 $3,000

304

109M

3.87M

1.12M

Ticker APLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 109,865,000
Market Cap $3.13B
Description
Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.